Effects of orthopedic implants with a polycaprolactone polymer coating containing bone morphogenetic protein-2 on osseointegration in bones of sheep

American Journal of Veterinary Research

Volumn 70, Issue 11, 2009, Pages 1416-1425

  Niehaus, Andrew J ^a   Anderson, David E ^a,c   Samii, Valerie F ^a   Weisbrode, Steven E ^a   Johnson, Jed K ^b   Noon, Mike S ^b   Tomasko, David L ^b   Lannutti, John J ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b The Ohio State University   (United States)

^c KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; BONE MORPHOGENETIC PROTEIN 2; POLYCAPROLACTONE; POLYMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE RADIOGRAPHY; BONE REGENERATION; BONE SCREW; CONTROLLED STUDY; ELUTION; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; IMPLANT; IN VITRO STUDY; IN VIVO STUDY; MALE; MATERIAL COATING; MORPHOMETRICS; NONHUMAN; PEAK REMOVAL TORQUE; SHEEP; TORQUE;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE SCREWS; COATED MATERIALS, BIOCOMPATIBLE; FEMALE; MALE; OSSEOINTEGRATION; POLYESTERS; SHEEP; TIME FACTORS;

ANIMALIA; OVIS ARIES;

EID: 70450263584     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.70.11.1416     Document Type: Article

References (38)

1. Puleo DA, Nanci A. Understanding and controlling the bone-implant interface. Biomaterials 1999;20:2311-2321.
2. Sundfeldt M, Carlsson LV, Johansson CB, et al. Aseptic loosening, not only a question of wear: a review of different theories. Acta Orthop 2006;77:177-197.
3. Gunston FH, MacKenzie RI. Complications of polycentric knee arthroplasty. Clin Orthop Relat Res 1976;120:11-17.
4. Vahvanen V, Vainio U. Arthroplasty of the knee joint. With special reference to complications. Scand J Rheumatol 1979;8:17-26. (Pubitemid 9155868)
5. Ota J, Cook JL, Lewis DD, et al. Short-term aseptic loosening of the femoral component in canine total hip replacement: effects of cementing technique on cement mantle grade. Vet Surg 2005;34:345-352. (Pubitemid 41695865)
6. Bogoni P, Rovesti GL. Early detection and treatment of screw loosening in triple pelvic osteotomy. Vet Surg 2005;34:190-195.
7. Doornink MT, Nieves MA, Evans R. Evaluation of ilial screw loosening after triple pelvic osteotomy in dogs: 227 cases (1991-1999). J Am Vet Med Assoc 2006;229:535-541.
8. Rai B, Teoh SH, Hutmacher DW, et al. Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2. Biomaterials 2005;26:3739-3748.
9. Aebli N, Stich H, Schawalder P, et al. Effects of bone morphogenetic protein-2 and hyaluronic acid on the osseointegration of hydroxyapatite-coated implants: an experimental study in sheep. J Biomed Mater Res A 2005;73:295-302.
10. Bessho K, Carnes DL, Cavin R, et al. BMP stimulation of bone response adjacent to titanium implants in vivo. Clin Oral Implants Res 1999;10:212-218.
11. Lan J, Wang Z, Wang Y, et al. The effect of combination of recombinant human bone morphogenetic protein-2 and basic fibroblast growth factor or insulin-like growth factor-I on dental implant osseointegration by confocal laser scanning microscopy. J Periodontol 2006;77:357-363. (Pubitemid 44740658)
12. Liu Y, de Groot K, Hunziker EB. BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model. Bone 2005;36:745-757. (Pubitemid 40626762)
13. Sailer HF, Kolb E. Application of purified bone morphogenetic protein (BMP) in cranio-maxillo-facial surgery. BMP in compromised surgical reconstructions using titanium implants. J Craniomaxillofac Surg 1994;22:2-11. (Pubitemid 124020029)
14. Shah AK, Lazatin J, Sinha RK, et al. Mechanism of BMP-2 stimulated adhesion of osteoblastic cells to titanium alloy. Biol Cell 1999;91:131-142. (Pubitemid 129672797)
15. Sigurdsson TJ, Fu E, Tatakis DN, et al. Bone morphogenetic protein-2 for peri-implant bone regeneration and osseointegration. Clin Oral Implants Res 1997;8:367-374. (Pubitemid 127688511)
16. Wikesjo UM, Polimeni G, Qahash M. Tissue engineering with recombinant human bone morphogenetic protein-2 for alveolar augmentation and oral implant osseointegration: experimental observations and clinical perspectives. Clin Implant Dent Relat Res 2005;7:112-119.
17. Yan MN, Tang TT, Zhu ZA, et al. Effects of bone morphogenetic protein-2 gene therapy on the bone-implant interface: an experimental study with dogs [in Chinese]. Zhonghua Yi Xue Za Zhi 2005;85:1521-1525.
18. Alden TD, Beres EJ, Laurent JS, et al. The use of bone morphogenetic protein gene therapy in craniofacial bone repair. J Craniofac Surg 2000;11:24-30.
19. Ripamonti U, Reddi AH. Growth and morphogenetic factors in bone induction: role of osteogenin and related bone morphogenetic proteins in craniofacial and periodontal bone repair. Crit Rev Oral Biol Med 1992;3:1-14.
20. Ayodeji O, Graham E, Kniss D, et al. Carbon dioxide impregnation of electrospun polycaprolactone fibers. J Supercritical Fluids 2007;41:173-178. (Pubitemid 46441778)
21. Powell HM, Ayodeji O, Summerfield TL, et al. Chemotherapeutic implants via subcritical CO2 modification. Biomaterials 2007;28:5562-5569. (Pubitemid 47599646)
22. Sproule TL, Lee JA, Li H, et al. Bioactive polymer surfaces via supercritical fluids. J Supercritical Fluids 2004;28:241-248.
23. Suzuki A, Terai H, Toyoda H, et al. A biodegradable delivery system for antibiotics and recombinant human bone morphogenetic protein-2: a potential treatment for infected bone defects. J Orthop Res 2006;24:327-332. (Pubitemid 43772992)
24. Agrawal CM, Best J, Heckman JD, et al. Protein release kinetics of a biodegradable implant for fracture non-unions. Biomaterials 1995;16:1255-1260.
25. Chikazu D, Li X, Kawaguchi H, et al. Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo. J Bone Miner Res 2002;17:1430-1440. (Pubitemid 34803827)
26. Rai B, Teoh SH, Ho KH, et al. The effect of rhBMP-2 on canine osteoblasts seeded onto 3D bioactive polycaprolactone scaffolds. Biomaterials 2004;25:5499-5506. (Pubitemid 38610188)
27. Lam CX, Savalani MM, Teoh SH, et al. Dynamics of in vitro polymer degradation of polycaprolactone-based scaffolds: accelerated versus simulated physiological conditions [published online ahead of print Aug 8, 2008]. Biomed Mater doi:10.1088/1748-6041/3/3/034108.
28. Geng Y, Discher DE. Hydrolytic degradation of poly(ethylene oxide)-block-polycaprolactone worm micelles. J Am Chem Soc 2005;127:12780-12781. (Pubitemid 41339148)
29. Cowan CM, Aalami OO, Shi YY, et al. Bone morphogenetic protein 2 and retinoic acid accelerate in vivo bone formation, osteoclast recruitment, and bone turnover. Tissue Eng 2005;11:645-658.
30. Martinovic S, Borovecki F, Miljavac V, et al. Requirement of a bone morphogenetic protein for the maintenance and stimulation of osteoblast differentiation. Arch Histol Cytol 2006;69:23-36.
31. Kemoun P, Laurencin-Dalicieux S, Rue J, et al. Human dental follicle cells acquire cementoblast features under stimulation by BMP-2/-7 and enamel matrix derivatives (EMD) in vitro. Cell Tissue Res 2007;329:283-294. (Pubitemid 47020512)
32. Itoh T, Mochizuki M, Fuda K, et al. Femoral nonunion fracture treated with recombinant human bone morphogenetic protein-2 in a dog. J Vet Med Sci 1998;60:535-538. (Pubitemid 128531794)
33. Schmiedt CW, Lu Y, Heaney K, et al. Comparison of two doses of recombinant human bone morphogenetic protein in absorbable collagen sponges for bone healing in dogs. Am J Vet Res 2007;68:834-840. (Pubitemid 47316950)
34. Jorgensen NR, Henriksen Z, Sorensen OH, et al. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids 2004;69:219-226. (Pubitemid 38748717)
35. Kim IS, Song YM, Cho TH, et al. In vitro response of primary human bone marrow stromal cells to recombinant human bone morphogenetic protein-2 in the early and late stages of osteoblast differentiation. Dev Growth Differ 2008;50:553-564.
36. Duan Z, Zheng Q, Guo X. Dose-dependence of bone morphogenetic protein 2-derived peptide on osteogenic induction in marrow mesenchymal stem cells in vitro [in Chinese]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2007;21:1118-1122.
37. Cowan CM, Aghaloo T, Chou YF, et al. MicroCT evaluation of three-dimensional mineralization in response to BMP-2 doses in vitro and in critical sized rat calvarial defects. Tissue Eng 2007;13:501-512. (Pubitemid 46579877)
38. Tamura S, Kataoka H, Matsui Y, et al. The effects of transplantation of osteoblastic cells with bone morphogenetic protein (BMP)/carrier complex on bone repair. Bone 2001;29:169-175. (Pubitemid 32734497)